Back to search
FDAFDA · Food and drugs·Recall number D-0004-2022

Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11

Published October 13, 2021 · Recall initiated: October 4, 2021

Summary

FDA records drug Class II recall D-0004-2022, published October 13, 2021 and initiated October 4, 2021. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 10,210 bottles; Lot: Lot 0B61A, Exp 01/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot 0B61A, Exp 01/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Betaxolol Ophthalmic Solution, USP, 0.5%, (Betaxolol HCl 5.6 mg/mL), 5 mL dropper bottle, Rx only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Carton NDC: 17478-705-10, Bottle NDC 17478-705-11 recalled?

Yes. FDA published recall D-0004-2022 on October 13, 2021. Reported hazard: Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter